What Happened
Rebecca Skloot’s “The Immortal Life of Henrietta Lacks” reveals a story that began in 1951 when Henrietta Lacks visited Johns Hopkins Hospital in Baltimore with severe abdominal pain. Doctors discovered she had an aggressive cervical cancer and, following standard practice at the time, removed tissue samples during her treatment without seeking her permission or informing her.
What made Henrietta’s cells extraordinary was their ability to survive and reproduce outside the human body—something scientists had been trying to achieve for decades. Named “HeLa” cells after the first two letters of her first and last names, these cells multiplied rapidly and seemed virtually immortal in laboratory conditions.
Tragically, Henrietta died from her cancer just eight months after her initial diagnosis, at age 31. She left behind five children and a husband, unaware that her cells would soon become one of the most important tools in medical research.
Why It Matters
HeLa cells have contributed to virtually every major medical advance over the past 70 years. Scientists used them to develop the polio vaccine in the 1950s, conduct early cancer research, test the effects of radiation and toxins, and study viruses including HIV. More than 74,000 scientific studies have been published using HeLa cells, and they’ve traveled to space aboard research missions.
The economic impact is staggering—companies have earned billions of dollars from products developed using HeLa cells. Yet the Lacks family received no compensation and, for decades, remained largely unaware of Henrietta’s massive contribution to science. Many of her descendants couldn’t afford health insurance, creating a painful irony where the family couldn’t access the medical advances their mother made possible.
Skloot’s book also exposes critical issues around medical ethics, informed consent, and racial inequality in healthcare that persist today. The story illustrates how medical research has historically exploited vulnerable populations, particularly poor patients and people of color.
Background
In the 1950s, informed consent as we know it today didn’t exist. Doctors routinely performed procedures and took tissue samples without explaining risks or obtaining explicit permission from patients. This practice was especially common when treating poor patients at public hospitals like Johns Hopkins, where Henrietta received care.
The medical establishment saw patients primarily as sources of research material rather than autonomous individuals with rights. Johns Hopkins served many African American patients in Baltimore, making it a prime location for researchers seeking tissue samples from a population with limited power to object.
Henrietta’s cells succeeded where countless others had failed because of a unique genetic mutation. Most human cells die after dividing a limited number of times, but HeLa cells contained an active enzyme called telomerase that allowed them to replicate indefinitely. This “immortality” made them invaluable for long-term research projects.
What’s Next
Skloot’s book, published in 2010, sparked important conversations about medical ethics and patient rights that continue today. Her decade-long relationship with the Lacks family helped bridge the gap between the scientific community and those whose contributions made research possible.
In 2013, the National Institutes of Health reached an agreement with the Lacks family giving them some control over how Henrietta’s genetic information is used in research. This represented a significant step toward recognizing the rights of tissue donors and their families.
The book has become required reading in many medical schools and ethics courses, helping train a new generation of healthcare professionals to consider the human stories behind their research. It demonstrates how scientists can honor the people whose biological materials advance medicine while maintaining rigorous research standards.
Modern regulations around informed consent are much stronger than in Henrietta’s time, but questions remain about how to fairly compensate individuals whose biological materials lead to profitable medical discoveries.
The Lasting Impact
“The Immortal Life of Henrietta Lacks” succeeds because it humanizes both sides of this complex story. Skloot doesn’t demonize the scientists who used Henrietta’s cells—many were genuinely trying to save lives and advance medicine. Instead, she shows how good intentions within a flawed system can perpetuate injustice.
The book reads like a thriller while tackling profound questions about dignity, exploitation, and progress. It challenges readers to consider who benefits from scientific advances and at what cost. Most importantly, it restores Henrietta Lacks’ identity, transforming her from an anonymous cell line back into a real person with a family, dreams, and a legacy that extends far beyond the laboratory.